Liquid Biopsy Spots Aggressive Pediatric Brainstem Cancer Earlier
News Nov 07, 2017 | Original story from Children's National Health System
A particularly aggressive form of pediatric cancer can be spotted reliably by the genetic fragments it leaves behind in children’s biofluids, opening the door to non-surgical biopsies and providing a way to gauge whether such tumors respond to treatment, according to an abstract presented by Children’s National Health System researchers during the Society for Neuro-Oncology (SNO) 2017 Annual Meeting.
Children diagnosed with diffuse midline histone 3 K27M mutant (H3K27M) glioma face a poor prognosis with a median survival time of only nine months after the pediatric brainstem cancer is diagnosed. Right now, clinicians rely on magnetic resonance imaging (MRI) to gauge how tumors are growing, but MRI can miss very small changes in tumor size. The Children’s research team led by Javad Nazarian, Ph.D., M.S.C., scientific director of the Brain Tumor Institute, tested whether circulating tumor DNA in patients’ blood and cerebrospinal fluid would provide an earlier warning that tumors were growing. Just as a detective looks for fingerprints left at a scene, the new genetic analysis technique can detect telltale signs that tumors leave behind in body fluids.
“We continue to push the envelope to find ways to provide hope for children and families who right now face a very dismal future. By identifying these tumors when they are small and potentially more responsive to treatment, our ultimate aim is to help children live longer,” says Eshini Panditharatna, B.A., study lead author. “In addition, we are hopeful that the comprehensive panel of tests we are constructing could identify which treatments are most effective in shrinking these deadly tumors.”
The researchers collected biofluid samples from 22 patients with diffuse intrinsic pontine glioma (DIPG) who were enrolled in a Phase I, Pacific Pediatric Neuro-Oncology Consortium clinical trial. Upfront and longitudinal plasma samples were collected with each MRI at various stages of disease progression. The team developed a liquid biopsy assay using a sensitive digital droplet polymerase chain reaction system that precisely counts individual DNA molecules.
“We detected H3K27M, a major driver mutation in DIPG, in about 80 percent of cerebrospinal fluid and plasma samples,” Panditharatna says. “Similar to adults with central nervous system (CNS) cancers, cerebrospinal fluid of children diagnosed with CNS cancers has high concentrations of circulating tumor DNA. However, after the children underwent radiotherapy, there was a dramatic decrease in circulating tumor DNA for 12 of the 15 patients (80 percent) whose temporal plasma was analyzed.”
Nazarian, the study senior author adds: “Biofluids, like plasma and cerebrospinal fluid, are suitable media to detect and measure concentrations of circulating tumor DNA for this type of pediatric glioma. Liquid biopsy has the potential to complement tissue biopsies and MRI evaluation to provide earlier clues to how tumors are responding to treatment or recurring.”
Support for this liquid biopsy study was provided by the V foundation, Goldwin Foundation, Pediatric Brain Tumor Foundation, Smashing Walnuts Foundation, the Zickler Family Foundation, the Piedmont Community Foundation, the Musella Foundation, the Mathew Larson Foundation and Brain Tumor Foundation for Children.
This article has been republished from materials provided by Children's National Health System. Note: material may have been edited for length and content. For further information, please contact the cited source.
Scientists Image the Brains of Stutterers to Find CauseNews
Scientists have now gained crucial insights into what makes a stutterer stutter.READ MORE
Increased Urea Levels in Brain Linked with Dementia.News
Members of the research team used cutting-edge gas chromatography mass spectrometry to measure brain urea levels.READ MORE
Neurophysiological Measurements of Inner Speech Reveal an Efferent CopyNews
New research showing that talking to ourselves in our heads may be the same as speaking our thoughts out loud could help explain why people with mental illnesses such as schizophrenia hear voices.READ MORE